These guides are AI-generated educational summaries — not legal or medical advice.
C&P Exam Prep: Kidney Transplant
DBQ Overview
Interview + Physical- Form Name
- kidney
- Form Code
- kidney
- Page Count
- 9
- Examiner Type
- Nephrologist or Urologist
- Estimated Duration
- 30-45 minutes
- Exam Format
- Interview + Physical
What to Expect During Your Exam
Exam Overview
To document the current severity of residual kidney dysfunction following transplant surgery for VA disability rating purposes under DC 7531. The exam establishes whether the 100% rating during the first post-transplant year is warranted, and thereafter evaluates residual renal dysfunction to assign a minimum 30% rating or higher based on actual functional impairment.
What the examiner evaluates:
- Confirmation of kidney transplant diagnosis, date of transplant surgery, and date of hospital discharge
- Current kidney function via eGFR, creatinine, BUN, and urinalysis results
- Presence and severity of chronic kidney disease (CKD) stages post-transplant
- Proteinuria (albuminuria) via ACR or 24-hour urine protein
- Immunosuppressive medication regimen and associated side effects
- Recurrent urinary tract or kidney infections
- Hypertension secondary to transplant or immunosuppression
- Rejection episodes (acute or chronic) and their treatment
- Post-transplant complications including anemia, electrolyte imbalances, bone disease
- Need for dialysis or re-transplant consideration
- Voiding dysfunction, hematuria, or obstructive uropathy
- Functional impact on daily activities, work, and quality of life
- History of hospitalizations, surgeries, and invasive/non-invasive procedures
- Status of native (original) kidneys if retained
- Any associated neoplasms given immunosuppression-related cancer risk
The exam will be conducted in person with a nephrologist or urologist. The examiner will review your VA claims file, service treatment records, and any private medical records available. Bring all laboratory reports, post-transplant follow-up records, and a current medication list. The examiner will also conduct a focused physical examination of the abdomen (transplant site), blood pressure measurement, and may review recent urine and blood test results. In most states you have the right to record the examination - confirm your state's rules in advance.
Typical duration: 30-45 minutes
Estimated Glomerular Filtration Rate (eGFR) / Serum Creatinine
Primary indicator of transplanted kidney function. eGFR estimates how well the kidney filters waste from blood; creatinine is a waste product that rises when kidney function declines.
What to expect:
The examiner will review your most recent laboratory values. Normal eGFR is -60 mL/min/1.73m-. Values below 60 indicate CKD; values below 15 indicate kidney failure. Bring the most recent labs from your transplant center.
Key thresholds:
- eGFR -60 mL/min/1.73m- — May support 30% minimum post-transplant rating if no other significant residuals
- eGFR 30-59 mL/min/1.73m- — Moderate CKD (Stage 3); supports higher residual dysfunction rating under 4.115a
- eGFR 15-29 mL/min/1.73m- — Severe CKD (Stage 4); may support 60-80% rating as renal dysfunction
- eGFR <15 mL/min/1.73m- — Kidney failure; supports 100% rating as renal dysfunction under 4.115a
Tips:
- Bring printed lab results from the past 6-12 months from your transplant center or nephrologist
- If your creatinine fluctuates, bring multiple dated results to show the range of your function
- Do not omit labs showing worse values - the VA rates based on your actual condition, not the best-case result
- Ask your transplant nephrologist for a summary letter documenting your current CKD stage
Pain considerations: Not directly painful but fatigue and nausea associated with declining eGFR are relevant functional symptoms to report during the exam.
Urine Albumin-to-Creatinine Ratio (ACR) / Proteinuria
Detects protein leaking into the urine, a key sign of ongoing kidney damage or transplant rejection. ACR -30 mg/g is considered abnormal and relevant to rating.
What to expect:
The DBQ specifically asks whether ACR -30 mg/g is present. The examiner may review recent urine tests or order a urinalysis at the exam. Bring any recent urine protein results.
Key thresholds:
- ACR <30 mg/g — Normal range; less evidence of active kidney damage
- ACR 30-300 mg/g (microalbuminuria) — Indicates kidney damage; supports continued higher-level rating
- ACR >300 mg/g (macroalbuminuria) — Significant proteinuria; supports higher residual dysfunction rating
Tips:
- Bring the most recent urine test results - spot urine ACR or 24-hour urine protein collection results are both relevant
- If you have had worsening proteinuria over time, bring serial results to document the trend
- Mention any symptoms associated with protein loss such as foamy urine, swelling in legs or feet, or fatigue
Pain considerations: Proteinuria itself is asymptomatic, but the underlying nephropathy causing it may produce fatigue, edema, and decreased exercise tolerance - describe these symptoms accurately.
Urinalysis (including casts, RBC, WBC)
Detects microscopic signs of kidney damage including RBC casts (glomerulonephritis), WBC casts (infection/inflammation), granular casts (tubular damage), and hematuria or pyuria.
What to expect:
The examiner will review recent urinalysis results. The DBQ has specific checkboxes for RBC casts, WBC casts, and granular casts. Bring any recent urinalysis reports.
Key thresholds:
- Presence of RBC casts — Indicates glomerular injury, may trigger evaluation of rejection or secondary nephropathy
- Presence of WBC casts — Suggests pyelonephritis or interstitial nephritis - supports infection/inflammation documentation
- Granular casts — Indicates tubular damage and chronic kidney disease progression
Tips:
- Bring recent urinalysis reports (within 6 months if possible)
- Note any recurrent urinary tract infections with dates and treatment courses
- If you have had episodes of blood in urine (hematuria), describe when they occurred and how they were treated
Pain considerations: Urinary tract infections and pyelonephritis can cause significant pain, urgency, and systemic symptoms - describe the full impact of any infections you have experienced.
Blood Pressure Measurement
Post-transplant hypertension is extremely common due to calcineurin inhibitor immunosuppressants (tacrolimus, cyclosporine) and chronic kidney disease. Hypertension severity is relevant to overall disability assessment.
What to expect:
Blood pressure will be measured at the exam. Bring documentation of home blood pressure readings and any anti-hypertensive medications prescribed.
Key thresholds:
- Well-controlled BP on medication — Hypertension may be separately ratable as secondary to transplant/immunosuppression
- Poorly controlled or resistant hypertension — Suggests more significant cardiovascular and renal residuals; document multiple medications required
Tips:
- Bring your anti-hypertensive medication list and note when each was started
- If you monitor blood pressure at home, bring a log or printout of readings
- Hypertension secondary to kidney transplant or immunosuppression may be separately ratable - ask your VSO about filing a secondary claim
Pain considerations: Hypertension-related headaches, dizziness, and fatigue are functional symptoms - report them accurately if present.
Immunosuppression Medication Assessment
Immunosuppressive drugs (tacrolimus, mycophenolate, prednisone, cyclosporine, sirolimus) are required for life after transplant and have significant side effects that affect daily functioning. The DBQ asks for all medications used for the diagnosed condition.
What to expect:
The examiner will ask about your complete immunosuppression regimen. The DBQ has a specific field asking you to list all medications taken for the condition with dates of use. Be thorough and accurate.
Key thresholds:
- Multi-drug immunosuppression regimen — Demonstrates ongoing treatment burden and supports continued rating; side effects may support secondary claims
- Dose adjustments due to rejection or toxicity — Documents instability of transplant function and ongoing intensive management
Tips:
- Bring a current, complete medication list including drug name, dose, and start date for every immunosuppressive medication
- Note all significant side effects you experience: tremors, infections, bone loss (osteoporosis), diabetes, weight gain, skin cancers, neuropathy
- Tacrolimus and cyclosporine are nephrotoxic and can damage the transplanted kidney over time - mention this to the examiner
- If you have required changes in immunosuppression due to rejection episodes, bring those records
Pain considerations: Steroid-related joint pain, mycophenolate-related GI symptoms, and tacrolimus-related neuropathy are common - describe how these side effects affect your daily functioning.
Rating Criteria Breakdown
| Rating % | Criteria | Key Symptoms |
|---|---|---|
| 100% | Assigned as of the date of hospital admission for kidney transplant surgery and continues for one year following hospital discharge. A mandatory VA examination is required at one year post-discharge. Any change in evaluation following that exam is subject to 38 CFR 3.105(e) reduction procedures. |
CFR: 38 CFR 4.115b DC 7531: 'The 100 percent evaluation shall be assigned as of the date of hospital admission for transplant surgery and shall continue with a mandatory VA examination one year following hospital discharge.' |
| 100% | After the first post-transplant year, rate on residuals as renal dysfunction. 100% residual rating applies when there is chronic renal failure requiring dialysis (eGFR <15 mL/min/1.73m-) or other criteria under 38 CFR 4.115a for the highest level of renal dysfunction. |
CFR: 38 CFR 4.115a: Renal dysfunction at the highest level - dialysis-dependent or equivalent functional impairment. Combined with DC 7531 minimum 30% floor, the residual rating framework under 4.115a applies. |
| 60% | Residual renal dysfunction post-transplant at a severe level - eGFR in the 15-29 range (Stage 4 CKD), significant proteinuria, requirement for continuous intensive management, persistent hypertension on multiple medications, or significant systemic complications of chronic immunosuppression. |
CFR: Rate as renal dysfunction under 38 CFR 4.115a. Continuous requirement for intensive management, persistent abnormal lab values, and significant systemic complications support this level. |
| 30% | Minimum rating after the first post-transplant year per DC 7531, regardless of residual severity. Also applicable when residual renal dysfunction is mild to moderate - eGFR 30-59 (Stage 3 CKD), mild-to-moderate proteinuria, controlled hypertension on medications, ongoing immunosuppression with manageable side effects. |
CFR: 38 CFR 4.115b DC 7531: 'Thereafter: Rate on residuals as renal dysfunction, minimum rating 30.' The 30% floor is guaranteed after the first post-transplant year under this diagnostic code. |
100% Assigned as of the date of hospital admission for kidney tra ...
Assigned as of the date of hospital admission for kidney transplant surgery and continues for one year following hospital discharge. A mandatory VA examination is required at one year post-discharge. Any change in evaluation following that exam is subject to 38 CFR 3.105(e) reduction procedures.
Key Symptoms
- Post-surgical recovery period
- Active immunosuppression initiation
- Monitoring for acute rejection
- Post-transplant hospitalization and intensive follow-up
- Dialysis dependency immediately post-transplant (delayed graft function)
CFR: 38 CFR 4.115b DC 7531: 'The 100 percent evaluation shall be assigned as of the date of hospital admission for transplant surgery and shall continue with a mandatory VA examination one year following hospital discharge.'
100% After the first post-transplant year, rate on residuals as r ...
After the first post-transplant year, rate on residuals as renal dysfunction. 100% residual rating applies when there is chronic renal failure requiring dialysis (eGFR <15 mL/min/1.73m-) or other criteria under 38 CFR 4.115a for the highest level of renal dysfunction.
Key Symptoms
- eGFR <15 mL/min/1.73m- (kidney failure stage)
- Requirement for dialysis (hemodialysis or peritoneal dialysis)
- Consideration for re-transplantation
- Severe anemia requiring transfusions
- Uremic symptoms: nausea, vomiting, altered mental status, severe fatigue
- Fluid overload, severe edema
- Electrolyte abnormalities requiring hospitalization
CFR: 38 CFR 4.115a: Renal dysfunction at the highest level - dialysis-dependent or equivalent functional impairment. Combined with DC 7531 minimum 30% floor, the residual rating framework under 4.115a applies.
60% Residual renal dysfunction post-transplant at a severe level ...
Residual renal dysfunction post-transplant at a severe level - eGFR in the 15-29 range (Stage 4 CKD), significant proteinuria, requirement for continuous intensive management, persistent hypertension on multiple medications, or significant systemic complications of chronic immunosuppression.
Key Symptoms
- eGFR 15-29 mL/min/1.73m- (Stage 4 CKD)
- Persistent heavy proteinuria (ACR >300 mg/g)
- Severe anemia of chronic kidney disease
- Multiple hospitalizations for rejection or complications
- Refractory hypertension requiring 3+ antihypertensive agents
- Significant bone disease (osteodystrophy, fractures)
- Frequent infections requiring hospitalization due to immunosuppression
- Significant functional impairment - inability to sustain full-time employment
CFR: Rate as renal dysfunction under 38 CFR 4.115a. Continuous requirement for intensive management, persistent abnormal lab values, and significant systemic complications support this level.
30% Minimum rating after the first post-transplant year per DC 7 ...
Minimum rating after the first post-transplant year per DC 7531, regardless of residual severity. Also applicable when residual renal dysfunction is mild to moderate - eGFR 30-59 (Stage 3 CKD), mild-to-moderate proteinuria, controlled hypertension on medications, ongoing immunosuppression with manageable side effects.
Key Symptoms
- eGFR 30-59 mL/min/1.73m- (Stage 3 CKD)
- Mild-to-moderate proteinuria (ACR 30-300 mg/g)
- Hypertension controlled on one to two medications
- Ongoing lifelong immunosuppression requirement
- Mild fatigue and reduced exercise tolerance
- Periodic monitoring labs and nephrology follow-up
- Suppressive drug therapy for recurrent infections
CFR: 38 CFR 4.115b DC 7531: 'Thereafter: Rate on residuals as renal dysfunction, minimum rating 30.' The 30% floor is guaranteed after the first post-transplant year under this diagnostic code.
How to Describe Your Symptoms
Fatigue and Energy Limitation
How to describe:
Describe how fatigue from kidney disease and immunosuppression affects your ability to complete daily activities, work, and exercise. Be specific: 'I can only walk one block before needing to rest' or 'I need to nap every afternoon for 1-2 hours due to exhaustion.' Connect fatigue to specific limitations like inability to maintain full-time work or complete household tasks.
Worst-day example:
“On my worst days, I am completely bedridden from exhaustion. I cannot cook, clean, drive, or leave the house. My fatigue is so severe I cannot concentrate on basic tasks. This happens approximately 8-10 days per month.”
What the examiner listens for:
Specific functional limitations tied to fatigue, frequency of severe episodes, and impact on employment and social functioning. The examiner needs to document functional impairment for the DBQ field on functional impact.
Understatements to avoid:
Do not say 'I get a little tired' when you mean you are functionally incapacitated on bad days. Do not minimize fatigue because you appear normal at the exam - describe your worst-day reality, not how you feel today.
Infection Frequency and Severity
How to describe:
Describe every urinary tract infection, kidney infection, pneumonia, or other serious infection you have had since transplant. Provide approximate dates, whether you were hospitalized, what antibiotics were used, and how long recovery took. Immunosuppression-related infections are a core part of your disability picture.
Worst-day example:
“Last year I was hospitalized for a severe kidney infection for five days. I had a fever of 103-F, could not eat, and needed IV antibiotics. It took three weeks to fully recover. I have had three UTIs requiring antibiotics in the past year alone.”
What the examiner listens for:
Frequency (how many per year), severity (outpatient vs. hospitalization), duration of recovery, need for suppressive antibiotics, and whether infections have caused impaired kidney function. The DBQ has specific fields for recurrent UTIs and their etiology.
Understatements to avoid:
Do not say 'I get infections sometimes' - provide specific counts, dates, and treatments. Do not omit hospitalizations for infections, as these are critical for rating purposes.
Immunosuppression Side Effects
How to describe:
Describe every significant side effect you experience from your anti-rejection medications. These are part of your service-connected disability burden. Common issues include: tremors from tacrolimus, GI problems from mycophenolate, weight gain and mood changes from prednisone, bone loss, elevated blood sugar, skin cancers, and increased infection susceptibility.
Worst-day example:
“My tacrolimus causes constant hand tremors so severe I cannot hold a pen steadily or button my shirt. My prednisone has caused 40 pounds of weight gain, diabetes, and bone fractures in my spine. My mycophenolate causes diarrhea so severe I cannot leave the house without planning access to a bathroom.”
What the examiner listens for:
Specific medication side effects with functional consequences, secondary conditions caused by immunosuppression, and how these side effects limit daily activities. Document every secondary condition for potential separate service-connected claims.
Understatements to avoid:
Do not omit medication side effects because you think they are 'just part of having a transplant.' Every functionally limiting side effect is relevant to your overall disability rating and potential secondary claims.
Voiding Dysfunction and Urinary Symptoms
How to describe:
Describe any urinary symptoms accurately: frequency, urgency, hesitancy, incontinence, painful urination, or decreased urine output. These symptoms are directly relevant to the genitourinary DBQ and can affect your rating. Note when symptoms are worst and what triggers them.
Worst-day example:
“On bad days I urinate 15 times in 24 hours and have episodes of urgency where I cannot make it to the bathroom in time. I wear protective undergarments daily due to incontinence. Nocturia wakes me 4-5 times per night, severely disrupting my sleep.”
What the examiner listens for:
Frequency, urgency, incontinence, nocturia frequency, and impact on sleep and daily activities. The DBQ has specific fields for voiding dysfunction - ensure the examiner understands the full scope of your urinary symptoms.
Understatements to avoid:
Do not underreport urinary frequency or incontinence out of embarrassment. These are medically relevant symptoms that directly affect your rating.
Post-Transplant Complications and Hospitalizations
How to describe:
Provide a complete history of every hospitalization, rejection episode, and complication since your transplant. Include dates, names of facilities, reason for admission, length of stay, and outcome. The DBQ specifically asks for hospitalization details. Rejection episodes, delayed graft function, vascular complications, and surgical re-interventions all belong in this history.
Worst-day example:
“I was hospitalized three times in the past two years: once for acute rejection (treated with high-dose steroids for 7 days inpatient), once for CMV pneumonia (10 days inpatient on IV ganciclovir), and once for a ureteral stricture that required stent placement. After each hospitalization my kidney function worsened and has never fully recovered.”
What the examiner listens for:
Frequency and severity of hospitalizations, whether treatment required inpatient stays, whether complications resulted in permanent reduction of kidney function, and the ongoing management burden.
Understatements to avoid:
Do not skip hospitalizations because they were 'a long time ago.' The full post-transplant course is relevant to establishing the severity and chronicity of your disability.
Functional Impact on Work and Daily Life
How to describe:
The DBQ has a specific field asking about functional impact. Be direct and specific: describe how your kidney transplant and its residuals affect your ability to work, perform household activities, socialize, exercise, travel, and care for yourself or your family. Quantify limitations where possible.
Worst-day example:
“I lost my job as a warehouse worker because I cannot lift heavy objects, work in extreme heat, or maintain a regular schedule due to frequent medical appointments, fatigue, and infections. I have to attend nephrology appointments every 4-6 weeks and spend approximately 8 hours per month in medical visits. I cannot plan travel due to the risk of infection and the need to maintain my medication schedule with refrigerated drugs.”
What the examiner listens for:
Specific work restrictions, loss of employment, inability to perform previous occupational duties, and concrete examples of how daily activities are limited. The examiner uses this to populate the functional impact field, which is critical for ratings and TDIU consideration.
Understatements to avoid:
Do not say 'I manage okay' if you have had to significantly change your life, reduce work hours, or stop working. Report the real impact on your worst days and your average functioning.
Common Mistakes to Avoid
Failing to bring transplant documentation to the exam
The DBQ requires specific information: date of transplant surgery, name and location of transplant facility, date of hospital admission and discharge. Without documentation, the examiner may leave these fields blank or record inaccurate dates, which can delay or reduce your rating.
Instead: Bring your transplant surgery records, hospital discharge summary, and any records from your transplant center. Prepare a written timeline with exact dates of transplant admission and discharge.
Impact: 100% (immediate post-transplant period)
Not reporting all post-transplant complications and hospitalizations
Each hospitalization, rejection episode, and complication documents the ongoing severity of your condition and the level of medical management required. The DBQ has multiple fields for hospitalization details. Omitting these leaves the examiner without critical evidence of disability severity.
Instead: Prepare a written list of every hospitalization, ER visit, and significant complication since transplant with dates, facility names, and reasons. Hand this to the examiner at the start of the appointment.
Impact: 60-100%
Minimizing symptoms because you feel 'relatively okay' on the day of the exam
The VA rates based on the average severity of your condition, including your worst days. Appearing well and downplaying symptoms on exam day can result in a rating that does not reflect your true functional impairment over time.
Instead: Describe your worst-day functioning honestly. Use phrases like 'On my worst days...' and 'On average I experience this X times per week/month.' Reference the M21-1 principle that the examiner should consider the full range of symptom severity.
Impact: 30-60%
Not listing all immunosuppressive medications and their side effects
The DBQ requires a complete medication list for the diagnosed condition. Immunosuppressive drugs are the lifelong treatment burden of kidney transplant. Their side effects are part of your disability picture and may support secondary claims for diabetes, osteoporosis, skin cancer, or hypertension.
Instead: Bring a printed medication list with drug name, dose, frequency, and start date. Separately document every significant side effect you experience from each medication. Ask your VSO about secondary service connection for conditions caused by immunosuppression.
Impact: 30-60%
Assuming the 30% minimum is guaranteed without confirmation on the DBQ
The 30% minimum under DC 7531 applies only when the kidney transplant is the diagnosed condition rated. If the examiner does not confirm the transplant diagnosis on the DBQ or rates only underlying conditions without noting the transplant, the minimum floor may not be applied correctly.
Instead: Ensure the examiner specifically checks the 'kidney transplant' checkbox on the DBQ and records the date of transplant. If you receive a rating below 30% after the first post-transplant year, this is an error - consult a VSO immediately.
Impact: 30% minimum
Not disclosing recurrent urinary tract or kidney infections
The DBQ has a specific field for etiology of recurrent UTIs or kidney infections. Recurrent infections document the ongoing functional burden of immunosuppression and may affect rating level, support suppressive drug therapy documentation, and establish secondary conditions.
Instead: Count and report every UTI and kidney infection in the past year and past few years. Note which required antibiotics, hospitalization, or IV treatment. Provide dates and treatment records if available.
Impact: 30-60%
Failing to mention voiding dysfunction or incontinence
Urinary symptoms (frequency, urgency, incontinence, nocturia) are directly relevant to the genitourinary DBQ and can affect your overall rating. Many veterans omit these symptoms out of embarrassment.
Instead: Report all urinary symptoms accurately. Use clinical language: 'urinary frequency,' 'urgency incontinence,' 'nocturia X times per night.' These symptoms document functional impairment that belongs in your rating.
Impact: 30-60%
Not requesting a copy of the completed DBQ after the exam
You have the right to request a copy of the DBQ. Reviewing it allows you to identify errors, omissions, or inaccurate characterizations of your symptoms before it is submitted to the VA rater.
Instead: At the end of the exam, ask the examiner or facility staff how you can obtain a copy of the completed DBQ. If errors are found, contact your VSO immediately to request a supplemental or corrected opinion.
Impact: All levels
Prep Checklist
Before Your Exam
Day Of
During the Exam
After the Exam
Your Rights During a C&P Exam
- You have the right to request that the C&P examiner review all evidence in your VA claims file before completing the DBQ - the examiner is required to do this.
- You have the right to bring a support person (caregiver, family member, VSO representative) to your C&P examination as an observer.
- You have the right to record your C&P examination in most states - verify your state's consent laws before the appointment. A recording provides an objective record of what was discussed.
- You have the right to request a copy of the completed DBQ after the examination. Review it carefully for errors and omissions.
- You have the right to submit a statement disagreeing with a C&P exam's findings. If the exam is inadequate, inaccurate, or fails to address the correct criteria, you can request a new examination or supplemental opinion.
- You have the right to submit your own independent medical opinion (IMO) or nexus letter from a private physician to supplement or rebut the VA examiner's opinion.
- Under 38 CFR 3.105(e), any reduction in your rating following the mandatory one-year post-transplant examination requires advance notice, an opportunity to submit evidence, and a predetermination hearing - the VA cannot reduce your rating without following this protective process.
- You have the right to submit buddy statements (VA Form 21-10210) from family members, caregivers, or others who can describe how your kidney transplant and its residuals affect your daily functioning.
- You have the right to a VA examination at no cost as part of the claims process. If you are unable to travel to the exam location due to your medical condition, you may request a home examination or telehealth examination accommodation.
- You have the right to appeal any rating decision you disagree with through the Supplemental Claim, Higher-Level Review, or Board of Veterans' Appeals lane under the Appeals Modernization Act.
Related Conditions
- Hypertension (Secondary to Kidney Transplant/Immunosuppression) Post transplant hypertension is extremely common, caused by calcineurin inhibitor immunosuppressants (tacrolimus, cyclosporine) and chronic kidney disease. May be separately ratable as secondary to DC 7531 under DC 7101.
- Post-Transplant Diabetes Mellitus (PTDM) New onset diabetes after transplant, caused by corticosteroids (prednisone) and calcineurin inhibitors, is a common immunosuppression complication. May be separately ratable as secondary to DC 7531 under DC 7913.
- Chronic Kidney Disease (CKD) - Residuals After the first post transplant year, DC 7531 rates on residuals as renal dysfunction under 38 CFR 4.115a. The CKD stage and eGFR level determine the rating level above the 30% minimum floor.
- Anemia of Chronic Kidney Disease Renal anemia is a common complication of CKD following transplant. If functionally significant (requiring treatment, causing fatigue and functional limitation), it may be separately ratable under the hematologic diagnostic codes.
- Osteoporosis/Avascular Necrosis (Secondary to Immunosuppression) Long term corticosteroid and calcineurin inhibitor use causes significant bone loss, osteoporosis, and avascular necrosis. These may be separately ratable as secondary conditions to DC 7531.
- Skin Cancer (Post-Transplant Squamous Cell Carcinoma) Immunosuppression dramatically increases the risk of cutaneous squamous cell carcinoma and other skin malignancies. Post transplant skin cancers may be separately ratable as secondary to DC 7531.
- Chronic Urinary Tract Infections / Recurrent Pyelonephritis Immunosuppression reduces the body's ability to fight urinary tract infections. Recurrent UTIs and pyelonephritis are common post transplant complications documented on the DBQ and may affect the overall renal dysfunction rating.
- Kidney Removal (Nephrectomy) of Native Kidney If the diseased native kidney was removed (nephrectomy) prior to or concurrent with transplant, DC 7500 (Kidney, removal of one) provides a separate minimum 30% rating for removal of one kidney. Both DC 7531 and DC 7500 may apply depending on surgical history.
- Peripheral Neuropathy (Secondary to Tacrolimus/Cyclosporine) Calcineurin inhibitor immunosuppressants can cause peripheral neuropathy manifesting as numbness, tingling, and pain in the extremities. If functionally significant, this may be separately ratable as secondary to DC 7531.
- Immunosuppression-Related GI Disorder Mycophenolate mofetil (CellCept) commonly causes significant gastrointestinal symptoms including diarrhea, nausea, vomiting, and abdominal pain. These may be separately ratable as secondary conditions to DC 7531 under the digestive system diagnostic codes.
Get Personalized C&P Exam Preparation
Upload your medical records for AI-powered prep that maps YOUR symptoms to the exact DBQ fields your examiner will evaluate.
This C&P exam preparation guide is for educational purposes only and does not constitute legal, medical, or claims advice. Always consult with a qualified Veterans Service Organization (VSO) representative or VA-accredited attorney for guidance specific to your claim. Never exaggerate, minimize, or fabricate symptoms during a C&P examination.